36C25023Q0501_1.docx
DOCX document 152 KB Posted
- Attached to
- 6505--Nuclear Medicine Radiopharmaceuticals
- Solicitation number
- 36C25023Q0501
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C25023Q0501 Line Item Fill-Ins for Prospective Contractors_Amendment 0001.xlsx | XLSX spreadsheet | |
| 36C25023Q0501 0001.docx | DOCX document | |
| 36C25023Q0501 Line Item Fill-Ins for Prospective Contractors.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
36C25023Q0501
PAGE 1 OF
1. REQUISITION NO.
2. CONTRACT NO.
3. AWARD/EFFECTIVE DATE
4. ORDER NO.
5. SOLICITATION NUMBER
6. SOLICITATION ISSUE DATE
a. NAME
b. TELEPHONE NO. (No Collect Calls)
8. OFFER DUE DATE/LOCAL
TIME
9. ISSUED BY
CODE
10. THIS ACQUISITION IS
UNRESTRICTED OR
SET ASIDE:
% FOR:
SMALL BUSINESS
HUBZONE SMALL
BUSINESS
SERVICE-DISABLED
VETERAN-OWNED
SMALL BUSINESS
WOMEN-OWNED SMALL BUSINESS
(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED
SMALL BUSINESS PROGRAM
EDWOSB
8(A)
NAICS:
SIZE STANDARD:
11. DELIVERY FOR FOB DESTINA-
TION UNLESS BLOCK IS
MARKED
SEE SCHEDULE
12. DISCOUNT TERMS
13a. THIS CONTRACT IS A
RATED ORDER UNDER
DPAS (15 CFR 700)
13b. RATING
14. METHOD OF SOLICITATION
RFQ
IFB
RFP
15. DELIVER TO
CODE
16. ADMINISTERED BY
CODE
17a. CONTRACTOR/OFFEROR
CODE
FACILITY CODE
18a. PAYMENT WILL BE MADE BY
CODE
TELEPHONE NO.
UEI:
EFT:
PHONE:
FAX:
17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED
SEE ADDENDUM
19.
20.
21.
22.
23.
24.
ITEM NO.
SCHEDULE OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
(Use Reverse and/or Attach Additional Sheets as Necessary)
25. ACCOUNTING AND APPROPRIATION DATA
26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA
ARE
ARE NOT ATTACHED.
27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA
ARE
ARE NOT ATTACHED
28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________
29. AWARD OF CONTRACT: REF. ___________________________________ OFFER
COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND
DATED ________________________________. YOUR OFFER ON SOLICITATION
DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY
(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE
ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED
SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:
30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED
AUTHORIZED FOR LOCAL REPRODUCTION
(REV. NOV 2021)
PREVIOUS EDITION IS NOT USABLE
Prescribed by GSA - FAR (48 CFR) 53.212
7. FOR SOLICITATION
INFORMATION CALL:
STANDARD FORM 1449
SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES
OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30
553-23-3-089-0076 36C25023Q0501 04-05-2023 Jeffrey Rozema 269-223-6450 04-14-2023
5:00 PM
EDT
36C250 Department of Veteran Affairs Network Contracting Office 10 Battle Creek VA Medical Center 5500 Armstrong Rd.
Battle Creek MI 49037 X 325412 1300 Employees N/A X 36C553 Department of Veterans Affairs John D. Dingell VA Medical Center C3503 4646 John R Street Detroit MI 48201 36C250 Department of Veteran Affairs Network Contracting Office 10 Battle Creek VA Medical Center 5500 Armstrong Road Battle Creek MI 49037
Department of Veteran Affairs
FMS-VA-2(101)
Financial Services Center PO Box 149971 Austin TX 78714-9971 512-242-7300 N/A X See CONTINUATION Page RFQ for 5-Year IDIQ Contract for Radiopharmaceuticals Period of Performance: 04/27/2023 - 04/26/2028 Please note: Use the attached Excel spreadsheet to complete pricing and product information.
See CONTINUATION Page 553-3630160-089-822900-2580 010022900 X X X Kellie Konopinski Contracting Officer Table of Contents
| SECTION B - CONTINUATION OF SF 1449 BLOCKS | 4 |
| B.1 CONTRACT ADMINISTRATION DATA | 4 |
| B.2 STATEMENT OF WORK | 5 |
| B.3 PRICE/COST SCHEDULE | 6 |
| ITEM INFORMATION | 6 |
| B.4 DELIVERY SCHEDULE | 43 |
| SECTION C - CONTRACT CLAUSES | 45 |
| C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022) | 45 |
| C.2 52.216-18 ORDERING (AUG 2020) | 51 |
| C.3 52.216-19 ORDER LIMITATIONS (OCT 1995) | 51 |
| C.4 52.216-22 INDEFINITE QUANTITY (OCT 1995) | 52 |
| C.5 COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS | 52 |
| C.6 52.232-40 PROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS (MAR 2023) | 53 |
| C.7 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022) | 54 |
| C.8 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018) | 54 |
| C.9 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION (OCT 2018) | 55 |
| C.10 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) | 56 |
| C.11 VAAR 852.247-71 DELIVERY LOCATION (OCT 2018) | 56 |
| C.12 VAAR 852.247-73 PACKING FOR DOMESTIC SHIPMENT (OCT 2018) | 56 |
| C.13 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) | 56 |
| C.14 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (MAR 2023) | 57 |
| SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS | 65 |
| SECTION E - SOLICITATION PROVISIONS | 66 |
| E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (MAR 2023) | 66 |
| E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021) | 70 |
| E.3 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018) | 73 |
| E.4 52.216-1 TYPE OF CONTRACT (APR 1984) | 74 |
| E.5 52.233-2 SERVICE OF PROTEST (SEP 2006) | 74 |
| E.6 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018) | 75 |
| E.7 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998) | 75 |
| E.8 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (NOV 2021) | 76 |
| E.9 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022) | 76 |
SECTION B - CONTINUATION OF SF 1449 BLOCKS
B.1 CONTRACT ADMINISTRATION DATA
1. Contract Administration: All contract administration matters will be handled by the following individuals:
a. CONTRACTOR: _________________________
POC: _________________________
PHONE: _________________________
EMAIL: _________________________
b. GOVERNMENT: Contract Specialist: Jeffrey Rozema Department of Veteran Affairs Network Contracting Office 10 Battle Creek VA Medical Center 5500 Armstrong Rd.
Battle Creek MI 49037
2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:
| [X] |
| 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or |
| [] |
| 52.232-36, Payment by Third Party |
3. INVOICES: Invoices shall be submitted in arrears:
| a. Quarterly | [] |
| b. Semi-Annually | [] |
| c. Other | [X] Monthly |
4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.
ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:
| AMENDMENT NO |
| DATE |
B.2 STATEMENT OF WORK
STATEMENT OF WORK
Contractor shall furnish (including packaging, transportation, manifests, and reports) all radiopharmaceuticals listed in the Schedule of Supplies to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 beginning April 27th, 2023 through April 26, 2028, and in strict accordance with all specifications, schedules, terms, conditions, and provisions of the solicitation and any resulting contract document:
1. All items under the terms of this contract shall be by a registered radio-pharmacist. Prior to acceptance of any items, the contractor shall provide documentation of the current licensure/registration of all personnel who will be performing under this contract.
2. Vendor will make available on a no cost basis to the Government, a “Trouble-Shooter” to assist in resolving problems in the use of the radiopharmaceuticals.
3. DELIVERY ORDERS: Estimated delivery orders will be issued to the Contractor as needed during the 5-year period of performance. John D. Dingell VA Medical Center Nuclear Medicine staff will contact the contractor via phone, fax, email, or other (preferred method to be determined after award) to have radiopharmaceutical deliveries made as needed.
4. Shipments must be labeled in accordance with all Federal, State and Local laws. A packing list must accompany all shipments and indicate date of shipment, contract number, purchase order number, items and quantities shipped.
5. All deliveries must be made as follows:
All couriers must park in the loading dock on Hancock and Brush. They must call x63375 from the telephone inside the building and await Police Staff. They will be escorted to Nuclear Medicine by Police and Security. Deliveries will then be made to:
Nuclear Medicine Hot Laboratory C3503 John D. Dingell VA Medical Center 4646 John R Street Detroit, MI 48201
6. A minimum of ½ of the expiration period must remain on the dated material. This applies to unmade kits only.
7. F.O.B. DESTINATION: Prices offered for supplies/services covered under this contract shall be F.O.B. Destination. There will be no additional charges added for shipping and/or special handling.
8. DELIVERY TIMES: The contractor shall attempt to provide one (1) hour delivery time during normal working hours: 8:00 a.m. to 4:30 p.m., Monday through Friday, excluding Federal holidays, and if 1-hour delivery time is not possible, inform the Nuclear Medicine personnel at the time the order is placed. The Contractor shall make delivery of orders within two (2) hours of order placement after normal working hours: 4:31 p.m. to 7:59 a.m., Monday through Friday, weekends, and Federal holidays, and if 2-hour delivery time is not possible, inform the Nuclear Medicine personnel at the time the order is placed. The ten (10) Federal Holidays celebrated by the Government are as follows:
| New Year’s Day | President’s Day | ||||||
| Birthday of Martin Luther King, Jr. | Memorial Day | ||||||
| Juneteenth National Independence Day | Independence Day | Labor Day | Columbus Day | Veterans Day | Thanksgiving Day | Christmas Day |
9. RETURN POLICY: Customer may return up to 5% Unit Dose products for full credit, provided the doses are unopened, unused, and shrink-wrapped. Any doses returned above this allowance will be billed as used doses. Contractor must be notified by fax with any returned doses.
10. QUALITY CONTROL: Products provided under this contract shall be in compliance with regulations and laws pertaining to dispensing and administration of radiopharmaceuticals to patients. The radio-pharmacy shall cooperate fully into any investigation by the Government or any agency thereof, of agents provided under this contract. In the event of misadministration due to mislabeling or mis-calibration of agents by the radio-pharmacy, they will assume full legal responsibility.
11. WASTE PRODUCTS: All waste products to include, but not limited to vials, needles, syringes, lead pigs, etc., will be picked up and disposed of by the contractor at no additional charge in accordance with all Federal, State and Local laws.
12. EXPIRATION TIME: All products that are prepared by the contractor shall be within the expiration time after reconstitution recommended by the manufacturer.
B.3 PRICE/COST SCHEDULE
Contract Minimum: TBD Contract Maximum: TBD
ITEM INFORMATION
| ITEM NUMBER |
| DESCRIPTION OF SUPPLIES/SERVICES |
| QUANTITY |
| UNIT |
| UNIT PRICE |
| AMOUNT |
| 1.00 |
| YR |
| __________________ |
| __________________ |
Contract for Radiopharmaceuticals - Year 1 Contract Period: Base POP Begin: 04-27-2023 POP End: 04-26-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals
0001AA
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-5mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AB
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-9mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AC
| 2.00 |
| EA |
| __________________ |
| __________________ |
In111 WBC- 500uCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 DTPA-1.5 mCi vial
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AE
| 2.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 2 caps-200 uCi(100uCi/cap)
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 1 caps-200 uCi(200uCi/cap)
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AG
| 2.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AH
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10-100 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AI
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag. Caps-3 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AJ
| 1.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag, Caps-100uCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AK
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-3.5mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AL
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-1.0 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AM
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-10mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AN
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-20mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AO
| 100.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MDP-20mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AP
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-2mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AQ
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-5mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AR
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m DTPA-15mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AS
| 20.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAA-5mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AT
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-Brain 30mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AU
| 2.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-WBC 30mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AV
| 25.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-25mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AW
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAG3-10mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AX
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99mPYP-15mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AY
| 1.00 |
| EA |
| __________________ |
| __________________ |
In 111 Octreoscan-6mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001AZ
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-10 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BA
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-30 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BB
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BC
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Mebrofenin-10 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 Oxine vial
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BE
| 1.00 |
| EA |
| __________________ |
| __________________ |
I123 Iobenguane-10 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 Ioflupane(Datscan) 5 mCi
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BG
| 25.00 |
| KT |
| __________________ |
| __________________ |
Pyrophosphate
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BH
| 1.00 |
| KT |
| __________________ |
| __________________ |
MAA
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BI
| 1.00 |
| KT |
| __________________ |
| __________________ |
Mebrofenin
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BJ
| 1.00 |
| KT |
| __________________ |
| __________________ |
MDP
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BK
| 1.00 |
| KT |
| __________________ |
| __________________ |
Sulfur Colloid
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BL
| 1.00 |
| KT |
| __________________ |
| __________________ |
DTPA
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BM
| 10.00 |
| KT |
| __________________ |
| __________________ |
UltraTag
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BN
| 10.00 |
| KT |
| __________________ |
| __________________ |
Sincalide (CCK) Sterile Water
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BO
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - Working Hours
POP Begin: 04-27-2023 POP End: 04-26-2024
0001BP
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - After Hours & Weekends
POP Begin: 04-27-2023 POP End: 04-26-2024
| 0.00 |
| YR |
| __________________ |
| __________________ |
Contract for Radiopharmaceuticals - Year 2
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AA
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-5mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AB
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-9mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AC
| 2.00 |
| EA |
| __________________ |
| __________________ |
In111 WBC- 500uCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 DTPA-1.5 mCi vial
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AE
| 2.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 2 caps-200 uCi(100uCi/cap)
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 1 caps-200 uCi(200uCi/cap)
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AG
| 2.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AH
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10-100 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AI
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag. Caps-3 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AJ
| 1.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag, Caps-100uCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AK
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-3.5mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AL
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-1.0 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AM
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-10mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AN
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-20mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AO
| 100.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MDP-20mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AP
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-2mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AQ
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-5mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AR
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m DTPA-15mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AS
| 20.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAA-5mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AT
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-Brain 30mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AU
| 2.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-WBC 30mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AV
| 25.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-25mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AW
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAG3-10mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AX
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99mPYP-15mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AY
| 1.00 |
| EA |
| __________________ |
| __________________ |
In 111 Octreoscan-6mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002AZ
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-10 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BA
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-30 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BB
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BC
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Mebrofenin-10 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 Oxine vial
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BE
| 1.00 |
| EA |
| __________________ |
| __________________ |
I123 Iobenguane-10 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 Ioflupane(Datscan) 5 mCi
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BG
| 25.00 |
| KT |
| __________________ |
| __________________ |
Pyrophosphate
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BH
| 1.00 |
| KT |
| __________________ |
| __________________ |
MAA
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BI
| 1.00 |
| KT |
| __________________ |
| __________________ |
Mebrofenin
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BJ
| 1.00 |
| KT |
| __________________ |
| __________________ |
MDP
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BK
| 1.00 |
| KT |
| __________________ |
| __________________ |
Sulfur Colloid
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BL
| 1.00 |
| KT |
| __________________ |
| __________________ |
DTPA
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BM
| 10.00 |
| KT |
| __________________ |
| __________________ |
UltraTag
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BN
| 10.00 |
| KT |
| __________________ |
| __________________ |
Sincalide (CCK) Sterile Water
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BO
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - Working Hours
POP Begin: 04-27-2024 POP End: 04-26-2025
0002BP
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - After Hours & Weekends
POP Begin: 04-27-2024 POP End: 04-26-2025
| 0.00 |
| YR |
| __________________ |
| __________________ |
Contract for Radiopharmaceuticals - Year 3
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AA
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-5mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AB
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-9mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AC
| 2.00 |
| EA |
| __________________ |
| __________________ |
In111 WBC- 500uCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 DTPA-1.5 mCi vial
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AE
| 2.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 2 caps-200 uCi(100uCi/cap)
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 1 caps-200 uCi(200uCi/cap)
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AG
| 2.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AH
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10-100 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AI
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag. Caps-3 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AJ
| 1.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag, Caps-100uCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AK
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-3.5mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AL
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-1.0 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AM
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-10mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AN
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-20mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AO
| 100.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MDP-20mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AP
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-2mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AQ
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-5mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AR
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m DTPA-15mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AS
| 20.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAA-5mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AT
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-Brain 30mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AU
| 2.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-WBC 30mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AV
| 25.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-25mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AW
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAG3-10mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AX
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99mPYP-15mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AY
| 1.00 |
| EA |
| __________________ |
| __________________ |
In 111 Octreoscan-6mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003AZ
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-10 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BA
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-30 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BB
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BC
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Mebrofenin-10 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 Oxine vial
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BE
| 1.00 |
| EA |
| __________________ |
| __________________ |
I123 Iobenguane-10 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 Ioflupane(Datscan) 5 mCi
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BG
| 25.00 |
| KT |
| __________________ |
| __________________ |
Pyrophosphate
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BH
| 1.00 |
| KT |
| __________________ |
| __________________ |
MAA
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BI
| 1.00 |
| KT |
| __________________ |
| __________________ |
Mebrofenin
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BJ
| 1.00 |
| KT |
| __________________ |
| __________________ |
MDP
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BK
| 1.00 |
| KT |
| __________________ |
| __________________ |
Sulfur Colloid
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BL
| 1.00 |
| KT |
| __________________ |
| __________________ |
DTPA
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BM
| 10.00 |
| KT |
| __________________ |
| __________________ |
UltraTag
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BN
| 10.00 |
| KT |
| __________________ |
| __________________ |
Sincalide (CCK) Sterile Water
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BO
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - Working Hours
POP Begin: 04-27-2025 POP End: 04-26-2026
0003BP
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - After Hours & Weekends
POP Begin: 04-27-2025 POP End: 04-26-2026
| 0.00 |
| YR |
| __________________ |
| __________________ |
Contract for Radiopharmaceuticals - Year 4
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AA
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-5mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AB
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-9mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AC
| 2.00 |
| EA |
| __________________ |
| __________________ |
In111 WBC- 500uCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 DTPA-1.5 mCi vial
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AE
| 2.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 2 caps-200 uCi(100uCi/cap)
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 1 caps-200 uCi(200uCi/cap)
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AG
| 2.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AH
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10-100 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AI
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag. Caps-3 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AJ
| 1.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag, Caps-100uCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AK
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-3.5mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AL
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-1.0 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AM
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-10mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AN
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-20mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AO
| 100.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MDP-20mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AP
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-2mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AQ
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-5mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AR
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m DTPA-15mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AS
| 20.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAA-5mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AT
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-Brain 30mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AU
| 2.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-WBC 30mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AV
| 25.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-25mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AW
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAG3-10mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AX
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99mPYP-15mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AY
| 1.00 |
| EA |
| __________________ |
| __________________ |
In 111 Octreoscan-6mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004AZ
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-10 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BA
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-30 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BB
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BC
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Mebrofenin-10 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 Oxine vial
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BE
| 1.00 |
| EA |
| __________________ |
| __________________ |
I123 Iobenguane-10 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 Ioflupane(Datscan) 5 mCi
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BG
| 25.00 |
| KT |
| __________________ |
| __________________ |
Pyrophosphate
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BH
| 1.00 |
| KT |
| __________________ |
| __________________ |
MAA
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BI
| 1.00 |
| KT |
| __________________ |
| __________________ |
Mebrofenin
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BJ
| 1.00 |
| KT |
| __________________ |
| __________________ |
MDP
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BK
| 1.00 |
| KT |
| __________________ |
| __________________ |
Sulfur Colloid
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BL
| 1.00 |
| KT |
| __________________ |
| __________________ |
DTPA
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BM
| 10.00 |
| KT |
| __________________ |
| __________________ |
UltraTag
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BN
| 10.00 |
| KT |
| __________________ |
| __________________ |
Sincalide (CCK) Sterile Water
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BO
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - Working Hours
POP Begin: 04-27-2026 POP End: 04-26-2027
0004BP
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - After Hours & Weekends
POP Begin: 04-27-2026 POP End: 04-26-2027
| 0.00 |
| YR |
| __________________ |
| __________________ |
Contract for Radiopharmaceuticals - Year 5
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AA
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-5mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AB
| 1.00 |
| EA |
| __________________ |
| __________________ |
Ga67 Citrate-9mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AC
| 2.00 |
| EA |
| __________________ |
| __________________ |
In111 WBC- 500uCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 DTPA-1.5 mCi vial
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AE
| 2.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 2 caps-200 uCi(100uCi/cap)
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 NAI Caps. 1 caps-200 uCi(200uCi/cap)
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AG
| 2.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AH
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Therapy Caps.-10-100 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AI
| 10.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag. Caps-3 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AJ
| 1.00 |
| EA |
| __________________ |
| __________________ |
I131 Diag, Caps-100uCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AK
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-3.5mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AL
| 3.00 |
| EA |
| __________________ |
| __________________ |
Tl201 Chloride-1.0 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AM
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-10mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AN
| 5.00 |
| EA |
| __________________ |
| __________________ |
Xe133 Gas-20mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AO
| 100.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MDP-20mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AP
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-2mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AQ
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sulfur Colloid-5mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AR
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m DTPA-15mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AS
| 20.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAA-5mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AT
| 1.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-Brain 30mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AU
| 2.00 |
| EA |
| __________________ |
| __________________ |
Tc99m HMPAO-WBC 30mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AV
| 25.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-25mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AW
| 5.00 |
| EA |
| __________________ |
| __________________ |
Tc99m MAG3-10mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AX
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99mPYP-15mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AY
| 1.00 |
| EA |
| __________________ |
| __________________ |
In 111 Octreoscan-6mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005AZ
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-10 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BA
| 220.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Sestamibi-30 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BB
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Pertechnetate-mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BC
| 10.00 |
| EA |
| __________________ |
| __________________ |
Tc99m Mebrofenin-10 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BD
| 1.00 |
| VI |
| __________________ |
| __________________ |
In111 Oxine vial
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BE
| 1.00 |
| EA |
| __________________ |
| __________________ |
I123 Iobenguane-10 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BF
| 10.00 |
| EA |
| __________________ |
| __________________ |
I123 Ioflupane(Datscan) 5 mCi
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BG
| 25.00 |
| KT |
| __________________ |
| __________________ |
Pyrophosphate
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BH
| 1.00 |
| KT |
| __________________ |
| __________________ |
MAA
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BI
| 1.00 |
| KT |
| __________________ |
| __________________ |
Mebrofenin
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BJ
| 1.00 |
| KT |
| __________________ |
| __________________ |
MDP
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BK
| 1.00 |
| KT |
| __________________ |
| __________________ |
Sulfur Colloid
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BL
| 1.00 |
| KT |
| __________________ |
| __________________ |
DTPA
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BM
| 10.00 |
| KT |
| __________________ |
| __________________ |
UltraTag
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BN
| 10.00 |
| KT |
| __________________ |
| __________________ |
Sincalide (CCK) Sterile Water
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BO
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - Working Hours
POP Begin: 04-27-2027 POP End: 04-26-2028
0005BP
| 25.00 |
| EA |
| __________________ |
| __________________ |
Emergency Delivery Fee - After Hours & Weekends
POP Begin: 04-27-2027 POP End: 04-26-2028
| GRAND TOTAL |
| __________________ |
B.4 DELIVERY SCHEDULE
| ITEM NUMBER |
| QUANTITY |
| DELIVERY DATE |
| 0001-0001BP |
| SHIP TO: |
| John D. Dingell VA Medical Center |
4646 John R Street Detroit, MI 48201
USA
| See Price/Cost Schedule |
| 04/27/2023 - 04/26/2024 |
| 0002-0002BP |
| SHIP TO: |
| John D. Dingell VA Medical Center |
4646 John R Street Detroit, MI 48201
USA
| See Price/Cost Schedule |
| 04/27/2024 - 04/26/2025 |
| 0003-0003BP |
| SHIP TO: |
| John D. Dingell VA Medical Center |
4646 John R Street Detroit, MI 48201
USA
| See Price/Cost Schedule |
| 04/27/2025 - 04/26/2026 |
| 0004-0004BP |
| SHIP TO: |
| John D. Dingell VA Medical Center |
4646 John R Street Detroit, MI 48201
USA
| See Price/Cost Schedule |
| 04/27/2026 - 04/26/2027 |
| 0005-0005BP |
| SHIP TO: |
| John D. Dingell VA Medical Center |
4646 John R Street Detroit, MI 48201
USA
| See Price/Cost Schedule |
| 04/27/2027 - 04/26/2028 |
36C25023Q0501
Page 1 of Page 1 of
SECTION C - CONTRACT CLAUSES
C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022)
(a) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post-acceptance rights—
(1) Within a reasonable time after the defect was discovered or should have been discovered; and
(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.
(b) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.
(c) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.
(d) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause at Federal Acquisition Regulation (FAR) 52.233-1, Disputes, which is incorporated herein by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.
(e) Definitions. The clause at FAR 52.202-1, Definitions, is incorporated herein by reference.
(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence such as, acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. The Contractor shall notify the Contracting Officer in writing as soon as it is reasonably possible after the commencement of any excusable delay, setting forth the full particulars in connection therewith, shall remedy such occurrence with all reasonable dispatch, and shall promptly give written notice to the Contracting Officer of the cessation of such occurrence.
(g) Invoice.
(1) The Contractor shall submit an original invoice and three copies (or electronic invoice, if authorized) to the address designated in the contract to receive invoices. An invoice must include—
(i) Name and address of the Contractor;
(ii) Invoice date and number;
(iii) Contract number, line item number and, if applicable, the order number;
(iv) Description, quantity, unit of measure, unit price and extended price of the items delivered;
(v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on Government bill of lading;
(vi) Terms of any discount for prompt payment offered;
(vii) Name and address of official to whom payment is to be sent;
(viii) Name, title, and phone number of person to notify in event of defective invoice; and
(ix) Taxpayer Identification Number (TIN). The Contractor shall include its TIN on the invoice only if required elsewhere in this contract.
(x) Electronic funds transfer (EFT) banking information.
(A) The Contractor shall include EFT banking information on the invoice only if required elsewhere in this contract.
(B) If EFT banking information is not required to be on the invoice, in order for the invoice to be a proper invoice, the Contractor shall have submitted correct EFT banking information in accordance with the applicable solicitation provision, contract clause (e.g., 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, or 52.232-34, Payment by Electronic Funds Transfer—Other Than System for Award Management), or applicable agency procedures.
(C) EFT banking information is not required if the Government waived the requirement to pay by EFT.
(2) Invoices will be handled in accordance with the Prompt Payment Act (31 U.S.C. 3903) and Office of Management and Budget (OMB) prompt payment regulations at 5 CFR part 1315.
(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.
(i) Payment.—
(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery destinations set forth in this contract.
(2) Prompt payment. The Government will make payment in accordance with the Prompt Payment Act (31 U.S.C. 3903) and prompt payment regulations at 5 CFR part 1315.
(3) Electronic Funds Transfer (EFT). If the Government makes payment by EFT, see 52.212-5(b) for the appropriate EFT clause.
(4) Discount. In connection with any discount offered for early payment, time shall be computed from the date of the invoice. For the purpose of computing the discount earned, payment shall be considered to have been made on the date which appears on the payment check or the specified payment date if an electronic funds transfer payment is made.
(5) Overpayments. If the Contractor becomes aware of a duplicate contract financing or invoice payment or that the Government has otherwise overpaid on a contract financing or invoice payment, the Contractor shall—
(i) Remit the overpayment amount to the payment office cited in the contract along with a description of the overpayment including the—
(A) Circumstances of the overpayment (e.g., duplicate payment, erroneous payment, liquidation errors, date(s) of overpayment);
(B) Affected contract number and delivery order number, if applicable;
(C) Affected line item or subline item, if applicable; and
(D) Contractor point of contact.
(ii) Provide a copy of the remittance and supporting documentation to the Contracting Officer.
(6) Interest.
(i) All amounts that become payable by the Contractor to the Government under this contract shall bear simple interest from the date due until paid unless paid within 30 days of becoming due. The interest rate shall be the interest rate established by the Secretary of the Treasury as provided in 41 U.S.C. 7109, which is applicable to the period in which the amount becomes due, as provided in (i)(6)(v) of this clause, and then at the rate applicable for each six-month period as fixed by the Secretary until the amount is paid.
(ii) The Government may issue a demand for payment to the Contractor upon finding a debt is due under the contract.
(iii) Final decisions. The Contracting Officer will issue a final decision as required by 33.211 if—
(A) The Contracting Officer and the Contractor are unable to reach agreement on the existence or amount of a debt within 30 days;
(B) The Contractor fails to liquidate a debt previously demanded by the Contracting Officer within the timeline specified in the demand for payment unless the amounts were not repaid because the Contractor has requested an installment payment agreement; or
(C) The Contractor requests a deferment of collection on a debt previously demanded by the Contracting Officer (see 32.607-2).
(iv) If a demand for payment was previously issued for the debt, the demand for payment included in the final decision shall identify the same due date as the original demand for payment.
(v) Amounts shall be due at the earliest of the following dates:
(A) The date fixed under this contract.
(B) The date of the first written demand for payment, including any demand for payment resulting from a default termination.
(vi) The interest charge shall be computed for the actual number of calendar days involved beginning on the due date and ending on—
(A) The date on which the designated office receives payment from the Contractor;
(B) The date of issuance of a Government check to the Contractor from which an amount otherwise payable has been withheld as a credit against the contract debt; or
(C) The date on which an amount withheld and applied to the contract debt would otherwise have become payable to the Contractor.
(vii) The interest charge made under this clause may be reduced under the procedures prescribed in FAR 32.608-2 in effect on the date of this contract.
(j) Risk of loss. Unless the contract specifically provides otherwise, risk of loss or damage to the supplies provided under this contract shall remain with the Contractor until, and shall pass to the Government upon:
(1) Delivery of the supplies to a carrier, if transportation is f.o.b. origin; or
(2) Delivery of the supplies to the Government at the destination specified in the contract, if transportation is f.o.b. destination.
(k) Taxes. The contract price includes all applicable Federal, State, and local taxes and duties.
(l) Termination for the Government's convenience. The Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop all work hereunder and shall immediately cause any and all of its suppliers and subcontractors to cease work. Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit the Contractor's records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.
(m) Termination for cause. The Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with adequate assurances of future performance. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience.
(n) Title. Unless specified elsewhere in this contract, title to items furnished under this contract shall pass to the Government upon acceptance, regardless of when or where the Government takes physical possession.
(o) Warranty. The Contractor warrants and implies that the items delivered hereunder are merchantable and fit for use for the particular purpose described in this contract.
(p) Limitation of liability. Except as otherwise provided by an express warranty, the Contractor will not be liable to the Government for consequential damages resulting from any defect or deficiencies in accepted items.
(q) Other compliances. The Contractor shall comply with all applicable Federal, State and local laws, executive orders, rules and regulations applicable to its performance under this contract.
(r) Compliance with laws unique to Government contracts. The Contractor agrees to comply with 31 U.S.C. 1352 relating to limitations on the use of appropriated funds to influence certain Federal contracts; 18 U.S.C. 431 relating to officials not to benefit; 40 U.S.C. chapter 37, Contract Work Hours and Safety Standards; 41 U.S.C. chapter 87, Kickbacks; 41 U.S.C. 4712 and 10 U.S.C. 4701 relating to whistleblower protections; 49 U.S.C. 40118, Fly American; and 41 U.S.C. chapter 21 relating to procurement integrity.
(s) Order of precedence. Any inconsistencies in this solicitation or contract shall be resolved by giving precedence in the following order:
(1) The schedule of supplies/services.
(2) The Assignments, Disputes, Payments, Invoice, Other Compliances, Compliance with Laws Unique to Government Contracts, and Unauthorized Obligations paragraphs of this clause;
(3) The clause at 52.212-5.
(4) Addenda to this solicitation or contract, including any license agreements for computer software.
(5) Solicitation provisions if this is a solicitation.
(6) Other paragraphs of this clause.
(7) The Standard Form 1449.
(8) Other documents, exhibits, and attachments
(9) The specification.
(t) [Reserved]
(u) Unauthorized Obligations.
(1) Except as stated in paragraph (u)(2) of this clause, when any supply or service acquired under this contract is subject to any End User License Agreement (EULA), Terms of Service (TOS), or similar legal instrument or agreement, that includes any clause requiring the Government to indemnify the Contractor or any person or entity for damages, costs, fees, or any other loss or liability that would create an Anti-Deficiency Act violation (31 U.S.C. 1341), the following shall govern:
(i) Any such clause is unenforceable against the Government.
(ii) Neither the Government nor any Government authorized end user shall be deemed to have agreed to such clause by virtue of it appearing in the EULA, TOS, or similar legal instrument or agreement.
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .